{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":30,"items":[{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T10:53:16Z","timestamp":1574419996568},"reference-count":3,"publisher":"Elsevier BV","issue":"2","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.mehy.2011.10.033","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T18:10:12Z","timestamp":1321553412000},"page":"349-350","source":"Crossref","is-referenced-by-count":3,"title":["Hpn protein as a mediator between Helicobacter pylori infection and Alzheimer\u2019s disease in sub-populations worldwide"],"prefix":"10.1016","volume":"78","author":[{"given":"Christos","family":"Zavos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Afroditi","family":"Tsona","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Konstantinos","family":"Mantzoukis","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Kiourtidis","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Pilpilidis","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Tzilves","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Vardaka","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711005603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711005603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T18:57:09Z","timestamp":1560970629000},"score":1.0,"issued":{"date-parts":[[2012,2]]},"references-count":3,"journal-issue":{"published-print":{"date-parts":[[2012,2]]},"issue":"2"},"alternative-id":["S0306987711005603"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2011.10.033","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T11:03:00Z","timestamp":1574506980361},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.mehy.2011.03.039","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T19:07:58Z","timestamp":1302894478000},"page":"109-111","source":"Crossref","is-referenced-by-count":3,"title":["Denosumab and bisphosphonates: Rivals or potential \u201cpartners\u201d? A \u201chybrid\u201d molecule hypothesis"],"prefix":"10.1016","volume":"77","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Chrysostomos D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T13:52:00Z","timestamp":1543845120000},"score":1.0,"issued":{"date-parts":[[2011,7]]},"references-count":14,"journal-issue":{"published-print":{"date-parts":[[2011,7]]},"issue":"1"},"alternative-id":["S0306987711001411"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2011.03.039","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T12:47:52Z","timestamp":1574513272874},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T00:00:00Z","timestamp":1351900800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00198-012-2198-0","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T17:09:05Z","timestamp":1351876145000},"page":"2127-2132","source":"Crossref","is-referenced-by-count":8,"title":["Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment"],"prefix":"10.1007","volume":"24","author":[{"given":"A. D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"P.","family":"Makras","sequence":"additional","affiliation":[]},{"given":"A.","family":"Gkiomisi","sequence":"additional","affiliation":[]},{"given":"M.","family":"Savvides","sequence":"additional","affiliation":[]},{"given":"A.","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"E.","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,11,3]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.10.009","volume":"359","author":"DM Kretser de","year":"2012","unstructured":"de Kretser DM, O'Hehir RE, Hardy CL, Hedger MP (2012) The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol Cell Endocrinol 359:101\u2013106","journal-title":"Mol Cell Endocrinol"},{"key":"2198_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-12-385961-7.00010-X","volume":"85","author":"C Payne","year":"2011","unstructured":"Payne C, King J, Hay D (2011) The role of activin\/nodal and Wnt signaling in endoderm formation. Vitam Horm 85:207\u2013216","journal-title":"Vitam Horm"},{"key":"2198_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/eje.0.1450225","volume":"145","author":"S Luisi","year":"2001","unstructured":"Luisi S, Florio P, Reis FM, Petraglia F (2001) Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 145:225\u2013236","journal-title":"Eur J Endocrinol"},{"key":"2198_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14310\/horm.2002.1308","volume":"10","author":"KA Toulis","year":"2011","unstructured":"Toulis KA, Anastasilakis AD, Polyzos S, Makras P (2011) Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis. Hormones (Athens) 10:174\u2013195","journal-title":"Hormones (Athens)"},{"key":"2198_CR5","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1096\/fj.07-8080com","volume":"21","author":"M Eijken","year":"2007","unstructured":"Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, van der Spek PJ, Visser JA, de Jong FH, Pols HA, van Leeuwen JP (2007) The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J 21:2949\u20132960","journal-title":"FASEB J"},{"key":"2198_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/en.143.1.74","volume":"143","author":"D Gaddy-Kurten","year":"2002","unstructured":"Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC (2002) Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74\u201383","journal-title":"Endocrinology"},{"key":"2198_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2009.07.001","volume":"310","author":"KM Nicks","year":"2009","unstructured":"Nicks KM, Perrien DS, Akel NS, Suva LJ, Gaddy D (2009) Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, activin and inhibin. Mol Cell Endocrinol 310:11\u201320","journal-title":"Mol Cell Endocrinol"},{"key":"2198_CR8","first-page":"4999","volume":"267","author":"M Hashimoto","year":"1992","unstructured":"Hashimoto M, Shoda A, Inoue S, Yamada R, Kondo T, Sakurai T et al (1992) Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem 267:4999\u20135004","journal-title":"J Biol Chem"},{"key":"2198_CR9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T","volume":"75","author":"T Ikenoue","year":"1999","unstructured":"Ikenoue T, Jingushi S, Urabe K, Okazaki K, Iwamoto Y (1999) Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells. J Cell Biochem 75:206\u2013214","journal-title":"J Cell Biochem"},{"key":"2198_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1315.023","volume":"1038","author":"W Vale","year":"2004","unstructured":"Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S (2004) Activins and inhibins and their signaling. Ann N Y Acad Sci 1038:142\u2013147","journal-title":"Ann N Y Acad Sci"},{"key":"2198_CR11","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S, Santo L, Cirstea D, Patel K, Sohani AR, Guimaraes A, Xie W, Chauhan D, Schoonmaker JA, Attar E, Churchill M, Weller E, Munshi N, Seehra J, Weissleder R, Anderson KC, Scadden DT, Raje N (2010) Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc Natl Acad Sci U S A 107:5124\u20135129","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2198_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu L, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125:247\u2013260","journal-title":"Cell"},{"key":"2198_CR13","unstructured":"Terpos E, Kastritis E, Christoulas D, Gkotzamanidou M, Eleutherakis-Papaiakovou E, Kanellias N, Papatheodorou A, Dimopoulos MA (2012) Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy. Ann Oncol 23:2681\u20132686","DOI":"10.1093\/annonc\/mds068","doi-asserted-by":"crossref"},{"key":"2198_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jcp.22272","volume":"225","author":"G Leto","year":"2010","unstructured":"Leto G (2010) Activin A and bone metastases. J Cell Physiol 225:302\u2013309","journal-title":"J Cell Physiol"},{"key":"2198_CR15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bone.2010.01.370","volume":"46","author":"S Lotinun","year":"2010","unstructured":"Lotinun S, Pearsall RS, Davies MV, Marvell TH, Monnell TE, Ucran J, Fajardo RJ, Kumar R, Underwood KW, Seehra J, Bouxsein ML, Baron R (2010) A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys. Bone 46:1082\u20131088","journal-title":"Bone"},{"key":"2198_CR16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1359\/jbmr.081208","volume":"24","author":"J Ruckle","year":"2009","unstructured":"Ruckle J, Jacobs M, Kramer W, Pearsall AE, Kumar R, Underwood KW, Seehra J, Yang Y, Condon CH, Sherman ML (2009) Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women. J Bone Miner Res 24:744\u2013752","journal-title":"J Bone Miner Res"},{"key":"2198_CR17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","volume":"346","author":"IR Reid","year":"2002","unstructured":"Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653\u2013661","journal-title":"N Engl J Med"},{"key":"2198_CR18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"2198_CR19","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1210\/jc.2010-1103","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S (2010) Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab 95:5063\u20135068","journal-title":"J Clin Endocrinol Metab"},{"key":"2198_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bone.2011.11.016","volume":"50","author":"GG Loots","year":"2012","unstructured":"Loots GG, Keller H, Leupin O, Murugesh D, Collette NM, Genetos DC (2012) TGF-\u03b2 regulates sclerostin expression via the ECR5 enhancer. Bone 50:663\u2013669","journal-title":"Bone"},{"key":"2198_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/bbrc.2000.2075","volume":"268","author":"K Fuller","year":"2000","unstructured":"Fuller K, Bayley KE, Chambers TJ (2000) Activin A is an essential cofactor for osteoclast induction. Biochem Biophys Res Commun 268:2\u20137","journal-title":"Biochem Biophys Res Commun"},{"key":"2198_CR22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0531-5565(01)00117-6","volume":"36","author":"A Baccarelli","year":"2001","unstructured":"Baccarelli A, Morpurgo PS, Corsi A, Vaghi I, Fanelli M, Cremonesi G, Vaninetti S, Beck-Peccoz P, Spada A (2001) Activin A serum levels and aging of the pituitary-gonadal axis: a cross-sectional study in middle-aged and elderly healthy subjects. Exp Gerontol 36:1403\u20131412","journal-title":"Exp Gerontol"},{"key":"2198_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.14310\/horm.2002.1303","volume":"10","author":"PN Singhellakis","year":"2011","unstructured":"Singhellakis PN, Malandrinou FC, Psarrou CJ, Danelli AM, Tsalavoutas SD, Constandellou ES (2011) Vitamin D deficiency in white, apparently healthy, free-living adults in a temperate region. Hormones (Athens) 10:131\u2013143","journal-title":"Hormones (Athens)"}],"container-title":["Osteoporosis International"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2198-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2198-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2198-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:50Z","timestamp":1558624130000},"score":1.0,"issued":{"date-parts":[[2012,11,3]]},"references-count":23,"journal-issue":{"published-print":{"date-parts":[[2013,7]]},"issue":"7"},"alternative-id":["2198"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00198-012-2198-0","relation":{"cites":[]},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T05:49:14Z","timestamp":1574488154836},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00198-010-1525-6","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T15:33:17Z","timestamp":1294673597000},"page":"1171-1176","source":"Crossref","is-referenced-by-count":67,"title":["Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide"],"prefix":"10.1007","volume":"23","author":[{"given":"S. A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"A. D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"C.","family":"Bratengeier","sequence":"additional","affiliation":[]},{"given":"W.","family":"Woloszczuk","sequence":"additional","affiliation":[]},{"given":"A.","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"E.","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,1,11]]},"reference":[{"key":"1525_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","volume":"87","author":"MJ Moester","year":"2010","unstructured":"Moester MJ, Papapoulos SE, Lowik CW, van Bezooijen RL (2010) Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 87:99\u2013107","journal-title":"Calcif Tissue Int"},{"key":"1525_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/156652410791065372","volume":"10","author":"R Trivedi","year":"2010","unstructured":"Trivedi R, Mithal A, Chattopadhyay N (2010) Anabolics in osteoporosis: the emerging therapeutic tool. Curr Mol Med 10:14\u201328","journal-title":"Curr Mol Med"},{"key":"1525_CR3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N, Van HE, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den EJ, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van HW (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537\u2013543","journal-title":"Hum Mol Genet"},{"key":"1525_CR4","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","volume":"19","author":"KE Poole","year":"2005","unstructured":"Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Lowik CW, Reeve J (2005) Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 19:1842\u20131844","journal-title":"FASEB J"},{"key":"1525_CR5","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D (2005) Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883\u201319887","journal-title":"J Biol Chem"},{"key":"1525_CR6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","volume":"417","author":"B Mao","year":"2002","unstructured":"Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C (2002) Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling. Nature 417:664\u2013667","journal-title":"Nature"},{"key":"1525_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14728210902766813","volume":"14","author":"EM Lewiecki","year":"2009","unstructured":"Lewiecki EM (2009) Emerging drugs for postmenopausal osteoporosis. Expert Opin Emerg Drugs 14:129\u2013144","journal-title":"Expert Opin Emerg Drugs"},{"key":"1525_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bone.2010.05.032","volume":"47","author":"X Tian","year":"2010","unstructured":"Tian X, Setterberg RB, Li X, Paszty C, Ke HZ, Jee WS (2010) Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats. Bone 47:529\u2013533","journal-title":"Bone"},{"key":"1525_CR9","author":"D Padhi","year":"2010","unstructured":"Padhi D, Jang G, Stouch B, Fang L, Posvar E (2010) Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res. doi: 10.1002\/jbmr.173","journal-title":"J Bone Miner Res"},{"key":"1525_CR10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1742-1241.2008.01768.x","volume":"62","author":"AD Anastasilakis","year":"2008","unstructured":"Anastasilakis AD, Goulis DG, Polyzos SA, Gerou S, Koukoulis GN, Efstathiadou Z, Kita M, Avramidis A (2008) Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. Int J Clin Pract 62:919\u2013924","journal-title":"Int J Clin Pract"},{"key":"1525_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2008-1046787","volume":"40","author":"AD Anastasilakis","year":"2008","unstructured":"Anastasilakis AD, Goulis DG, Polyzos SA, Gerou S, Koukoulis G, Kita M, Avramidis A (2008) Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial. Horm Metab Res 40:281\u2013285","journal-title":"Horm Metab Res"},{"key":"1525_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2265.2009.03728.x","volume":"72","author":"AD Anastasilakis","year":"2010","unstructured":"Anastasilakis AD, Polyzos SA, Avramidis A, Toulis KA, Papatheodorou A, Terpos E (2010) The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis. Clin Endocrinol Oxf 72:752\u2013757","journal-title":"Clin Endocrinol Oxf"},{"key":"1525_CR13","author":"UI Modder","year":"2010","unstructured":"Modder UI, Hoey KA, Amin S, McCready LK, Achenbach SJ, Lawrence RB, Joseph ML III, Khosla S (2010) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res. doi: 10.1002\/jbmr.217","journal-title":"J Bone Miner Res"},{"key":"1525_CR14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00198-005-1871-y","volume":"16","author":"LJ Melton III","year":"2005","unstructured":"Melton LJ III, Looker AC, Shepherd JA, O\u2019Connor MK, Achenbach SJ, Riggs BL, Khosla S (2005) Osteoporosis assessment by whole body region vs. site-specific DXA. Osteoporos Int 16:1558\u20131564","journal-title":"Osteoporos Int"},{"key":"1525_CR15","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, Srinivasan B, Modder UI, Peterson JM, McCready LK, Riggs BL, Dwyer D, Stolina M, Kostenuik P, Khosla S (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 95:5056\u20135062","journal-title":"J Clin Endocrinol Metab"},{"key":"1525_CR16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","volume":"95","author":"FS Mirza","year":"2010","unstructured":"Mirza FS, Padhi ID, Raisz LG, Lorenzo JA (2010) Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 95:1991\u20131997","journal-title":"J Clin Endocrinol Metab"},{"key":"1525_CR17","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","volume":"95","author":"A Gaudio","year":"2010","unstructured":"Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95:2248\u20132253","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1525-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1525-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1525-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:54:51Z","timestamp":1559933691000},"score":1.0,"issued":{"date-parts":[[2011,1,11]]},"references-count":17,"journal-issue":{"published-print":{"date-parts":[[2012,3]]},"issue":"3"},"alternative-id":["1525"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00198-010-1525-6","relation":{"cites":[]},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T00:20:06Z","timestamp":1574554806971},"reference-count":162,"publisher":"Elsevier BV","issue":"1","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.metabol.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T06:01:20Z","timestamp":1414044080000},"page":"60-78","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Leptin in nonalcoholic fatty liver disease: A narrative review"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T14:47:52Z","timestamp":1565966872000},"score":1.0,"issued":{"date-parts":[[2015,1]]},"references-count":162,"journal-issue":{"published-print":{"date-parts":[[2015,1]]},"issue":"1"},"alternative-id":["S0026049514003060"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2014.10.012","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptin in nonalcoholic fatty liver disease: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T17:39:34Z","timestamp":1574703574736},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.metabol.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T12:05:21Z","timestamp":1434197121000},"page":"937-942","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["An update on the validity of irisin assays and the link between irisin and hepatic metabolism"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515001663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515001663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T21:22:01Z","timestamp":1537564921000},"score":1.0,"issued":{"date-parts":[[2015,9]]},"references-count":46,"journal-issue":{"published-print":{"date-parts":[[2015,9]]},"issue":"9"},"alternative-id":["S0026049515001663"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.06.005","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on the validity of irisin assays and the link between irisin and hepatic metabolism","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.01.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T07:34:02Z","timestamp":1574580842371},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejim.2015.01.015","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T14:37:36Z","timestamp":1423492656000},"page":"152-153","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating homocysteine in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Michael A.","family":"Tsoukas","sequence":"additional","affiliation":[]}],"member":"78","container-title":["European Journal of Internal Medicine"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T19:51:17Z","timestamp":1566330677000},"score":1.0,"issued":{"date-parts":[[2015,3]]},"references-count":10,"journal-issue":{"published-print":{"date-parts":[[2015,3]]},"issue":"2"},"alternative-id":["S0953620515000345"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.ejim.2015.01.015","ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating homocysteine in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T13:25:24Z","timestamp":1574688324854},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":145,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1111\/hel.12228","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T07:25:33Z","timestamp":1428564333000},"page":"405-409","source":"Crossref","is-referenced-by-count":8,"title":["Novel Advances in the Association BetweenHelicobacter pyloriInfection, Metabolic Syndrome, and Related Morbidity"],"prefix":"10.1111","volume":"20","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[{"name":"Department of Medicine; Second Medical Clinic; Aristotle University of Thessaloniki; Ippokration Hospital; Thessaloniki Greece"}]},{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[{"name":"Department of Medicine; Second Medical Clinic; Aristotle University of Thessaloniki; Ippokration Hospital; Thessaloniki Greece"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"10.1111\/hel.12228-BIB0001|hel12228-cit-0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1523-5378.2011.00822.x","article-title":"The association between Helicobacter pylori infection and insulin resistance: a systematic review","volume":"16","author":"Polyzos","year":"2011","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0002|hel12228-cit-0002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2012.06.007","article-title":"Helicobacter pylori infection in patients with nonalcoholic fatty liver disease","volume":"62","author":"Polyzos","year":"2013","journal-title":"Metabolism"},{"key":"10.1111\/hel.12228-BIB0003|hel12228-cit-0003","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.mehy.2014.03.003","article-title":"Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease","volume":"82","author":"Polyzos","year":"2014","journal-title":"Med Hypotheses"},{"key":"10.1111\/hel.12228-BIB0004|hel12228-cit-0004","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gie.2014.01.054","article-title":"Helicobacter pylori-related metabolic syndrome might justify earlier colorectal cancer screening","volume":"80","author":"Romiopoulos","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"Suppl 1","key":"10.1111\/hel.12228-BIB0005|hel12228-cit-0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hel.12071","article-title":"Diagnosis and epidemiology of Helicobacter pylori infection","volume":"18","author":"Calvet","year":"2013","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"10.1111\/hel.12228-BIB0006|hel12228-cit-0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0007|hel12228-cit-0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1751-2980.2010.00469.x","article-title":"Epidemiology of the metabolic syndrome in the USA","volume":"12","author":"McCullough","year":"2011","journal-title":"J Dig Dis"},{"issue":"Suppl 1","key":"10.1111\/hel.12228-BIB0008|hel12228-cit-0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1523-5378.2012.00983.x","article-title":"Extragastric manifestations of Helicobacter pylori infection","volume":"17","author":"Banic","year":"2012","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0009|hel12228-cit-0009","author":"Chen","year":"2015","article-title":"Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study","journal-title":"Helicobacter","DOI":"10.1111\/hel.12190","doi-asserted-by":"crossref"},{"issue":"Suppl 1","key":"10.1111\/hel.12228-BIB0010|hel12228-cit-0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/hel.12161","article-title":"Diagnosis of Helicobacter pylori infection","volume":"19","author":"Megraud","year":"2014","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0011|hel12228-cit-0011","author":"Nam","year":"2014","article-title":"Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0012|hel12228-cit-0012","author":"Liu","year":"2014","article-title":"Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20,000 participants","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0013|hel12228-cit-0013","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/hel.12228-BIB0014|hel12228-cit-0014","author":"Zhou","year":"2015","article-title":"Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun\/miR-203\/SOCS3 signaling pathway","journal-title":"J Gastroenterol","DOI":"10.1007\/s00535-015-1051-6","doi-asserted-by":"crossref"},{"key":"10.1111\/hel.12228-BIB0015|hel12228-cit-0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3748\/wjg.v20.i3.647","article-title":"Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery","volume":"20","author":"Carabotti","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/hel.12228-BIB0016|hel12228-cit-0016","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/bmj.316.7138.1130","article-title":"Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies","volume":"316","author":"Danesh","year":"1998","journal-title":"BMJ"},{"key":"10.1111\/hel.12228-BIB0017|hel12228-cit-0017","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/hel.12228-BIB0018|hel12228-cit-0018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2013-305092","article-title":"Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response","volume":"63","author":"Ericksen","year":"2014","journal-title":"Gut"},{"key":"10.1111\/hel.12228-BIB0019|hel12228-cit-0019","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.gastro.2015.01.040","article-title":"Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits","volume":"148","author":"Graham","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/hel.12228-BIB0020|hel12228-cit-0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4103\/1319-3767.87190","article-title":"Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact","volume":"17","author":"Polyzos","year":"2011","journal-title":"Saudi J Gastroenterol"},{"key":"10.1111\/hel.12228-BIB0021|hel12228-cit-0021","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1523-5378.2009.00705.x","article-title":"Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population","volume":"14","author":"Gunji","year":"2009","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0022|hel12228-cit-0022","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1523-5378.2012.00970.x","article-title":"Association of H.\u00a0pylori infection with insulin resistance and metabolic syndrome among lebanese adults","volume":"17","author":"Naja","year":"2012","journal-title":"Helicobacter"},{"key":"10.1111\/hel.12228-BIB0023|hel12228-cit-0023","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2337\/dc11-1043","article-title":"Helicobacter pylori infection is associated with an increased rate of diabetes","volume":"35","author":"Jeon","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1111\/hel.12228-BIB0024|hel12228-cit-0024","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bpg.2014.10.004","article-title":"The gastrointestinal microbiome - functional interference between stomach and intestine","volume":"28","author":"Lopetuso","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/hel.12228-BIB0025|hel12228-cit-0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MCO.0000000000000067","article-title":"Gut microbiota composition and its effects on obesity and insulin resistance","volume":"17","author":"Caricilli","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1111\/hel.12228-BIB0026|hel12228-cit-0026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","article-title":"Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease","volume":"46","author":"Polyzos","year":"2012","journal-title":"J Clin Gastroenterol"}],"container-title":["Helicobacter"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhel.12228","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:59:46Z","timestamp":1498208386000},"score":1.0,"issued":{"date-parts":[[2015,4,9]]},"references-count":26,"journal-issue":{"published-print":{"date-parts":[[2015,12]]},"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1111\/hel.12228","archive":["Portico"],"relation":{"cites":[]},"ISSN":["1083-4389"],"issn-type":[{"value":"1083-4389","type":"print"}]},{"indexed":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T14:02:00Z","timestamp":1574690520399},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.metabol.2015.04.006","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T23:19:55Z","timestamp":1430608795000},"page":"888-895","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intracellular leptin signaling following effective weight loss"],"prefix":"10.1016","volume":"64","author":[{"given":"Ayse","family":"Sahin-Efe","sequence":"first","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Fadime","family":"Dincer","sequence":"additional","affiliation":[]},{"given":"Lesya","family":"Zaichenko","sequence":"additional","affiliation":[]},{"given":"Rosemary","family":"McGovern","sequence":"additional","affiliation":[]},{"given":"Benjamin","family":"Schneider","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T23:26:34Z","timestamp":1537658794000},"score":1.0,"issued":{"date-parts":[[2015,8]]},"references-count":44,"journal-issue":{"published-print":{"date-parts":[[2015,8]]},"issue":"8"},"alternative-id":["S0026049515001110"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.04.006","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular leptin signaling following effective weight loss","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:08:21Z","timestamp":1574726901611},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.metabol.2015.09.001","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T11:20:11Z","timestamp":1442056811000},"page":"1611-1618","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Irisin: A true, circulating hormone"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Hannah","family":"Mathew","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951500253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951500253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:26:05Z","timestamp":1537363565000},"score":1.0,"issued":{"date-parts":[[2015,12]]},"references-count":32,"journal-issue":{"published-print":{"date-parts":[[2015,12]]},"issue":"12"},"alternative-id":["S002604951500253X"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.09.001","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irisin: A true, circulating hormone","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T07:22:02Z","timestamp":1574752922952},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.metabol.2015.12.009","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T08:32:34Z","timestamp":1450859554000},"page":"1007-1016","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nonalcoholic fatty future disease"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T17:26:29Z","timestamp":1537118789000},"score":1.0,"issued":{"date-parts":[[2016,8]]},"references-count":46,"journal-issue":{"published-print":{"date-parts":[[2016,8]]},"issue":"8"},"alternative-id":["S0026049515003741"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.12.009","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty future disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:01:18Z","timestamp":1574744478376},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12020-015-0803-7","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T09:53:42Z","timestamp":1447926822000},"page":"4-6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Periostin on the road to nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"803_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"9","author":"SA Polyzos","year":"2009","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr. Mol. Med. 9, 299\u2013314 (2009)","journal-title":"Curr. Mol. Med."},{"key":"803_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"S.A. Polyzos, C.S. Mantzoros, Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63, 161\u2013167 (2014)","journal-title":"Metabolism"},{"key":"803_CR3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, G. Deretzi, Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J. Clin. Gastroenterol. 46, 272\u2013284 (2012)","journal-title":"J. Clin. Gastroenterol."},{"key":"803_CR4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.matbio.2014.04.007","volume":"37","author":"AY Liu","year":"2014","unstructured":"A.Y. Liu, H. Zheng, G. Ouyang, Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol. 37, 150\u2013156 (2014)","journal-title":"Matrix Biol."},{"key":"803_CR5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1210\/jc.2013-3893","volume":"99","author":"JC Rousseau","year":"2014","unstructured":"J.C. Rousseau, E. Sornay-Rendu, C. Bertholon, R. Chapurlat, P. Garnero, Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. J. Clin. Endocrinol. Metab. 99, 2533\u20132539 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"803_CR6","first-page":"145","volume":"46","author":"AD Anastasilakis","year":"2014","unstructured":"A.D. Anastasilakis, S.A. Polyzos, P. Makras, M. Savvides, G.T. Sakellariou, A. Gkiomisi, A. Papatheodorou, E. Terpos, Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment. Horm. Metab. Res. 46, 145\u2013149 (2014)","journal-title":"Horm. Metab. Res."},{"key":"803_CR7","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1172\/JCI74438","volume":"124","author":"Y Lu","year":"2014","unstructured":"Y. Lu, X. Liu, Y. Jiao, X. Xiong, E. Wang, X. Wang, Z. Zhang, H. Zhang, L. Pan, Y. Guan, D. Cai, G. Ning, X. Li, Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPAR\u03b1. J. Clin. Invest. 124, 3501\u20133513 (2014)","journal-title":"J. Clin. Invest."},{"key":"803_CR8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jhep.2014.10.005","volume":"62","author":"Y Li","year":"2015","unstructured":"Y. Li, S. Wu, S. Xiong, G. Ouyang, Deficiency of periostin protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis. J. Hepatol. 62, 495\u2013497 (2015)","journal-title":"J. Hepatol."},{"key":"803_CR9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ajpath.2014.11.002","volume":"185","author":"Y Huang","year":"2015","unstructured":"Y. Huang, W. Liu, H. Xiao, A. Maitikabili, Q. Lin, T. Wu, Z. Huang, F. Liu, Q. Luo, G. Ouyang, Matricellular protein periostin contributes to hepatic inflammation and fibrosis. Am. J. Pathol. 185, 786\u2013797 (2015)","journal-title":"Am. J. Pathol."},{"key":"803_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molimm.2014.10.021","volume":"64","author":"S Amara","year":"2015","unstructured":"S. Amara, K. Lopez, B. Banan, S.K. Brown, M. Whalen, E. Myles, M.T. Ivy, T. Johnson, K.L. Schey, V. Tiriveedhi, Synergistic effect of pro-inflammatory TNF\u03b1 and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis. Mol. Immunol. 64, 26\u201335 (2015)","journal-title":"Mol. Immunol."},{"key":"803_CR11","author":"JZ Zhu","year":"2015","unstructured":"J.Z. Zhu, H.T. Zhu, Y.N. Dai, C.X. Li, Z.Y. Fang, D.J. Zhao, X.Y. Wan, Y.M. Wang, F. Wang, C.H. Yu, Y.M. Li, Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Endocrine (2015). doi: 10.1007\/s12020-015-0735-2","journal-title":"Endocrine"},{"key":"803_CR12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ejso.2013.06.023","volume":"39","author":"Y Lv","year":"2013","unstructured":"Y. Lv, W. Wang, W.D. Jia, Q.K. Sun, M. Huang, H.C. Zhou, H.H. Xia, W.B. Liu, H. Chen, S.N. Sun, G.L. Xu, High preoperative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Eur. J. Surg. Oncol. 39, 1129\u20131135 (2013)","journal-title":"Eur. J. Surg. Oncol."},{"key":"803_CR13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/mt.2013.30","volume":"21","author":"YJ Lee","year":"2013","unstructured":"Y.J. Lee, I.S. Kim, S.A. Park, Y. Kim, J.E. Lee, D.Y. Noh, K.T. Kim, S.H. Ryu, P.G. Suh, Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis. Mol. Ther. 21, 1004\u20131013 (2013)","journal-title":"Mol. Ther."},{"key":"803_CR14","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3748\/wjg.v21.i9.2605","volume":"21","author":"GX Liu","year":"2015","unstructured":"G.X. Liu, H.Q. Xi, X.Y. Sun, B. Wei, Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis. World J. Gastroenterol. 21, 2605\u20132613 (2015)","journal-title":"World J. Gastroenterol."}],"container-title":["Endocrine"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0803-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0803-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0803-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:14Z","timestamp":1559440634000},"score":1.0,"issued":{"date-parts":[[2015,11,19]]},"references-count":14,"journal-issue":{"published-print":{"date-parts":[[2016,1]]},"issue":"1"},"alternative-id":["803"],"URL":"http:\/\/dx.doi.org\/10.1007\/s12020-015-0803-7","relation":{"cites":[]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:20:15Z","timestamp":1574745615048},"reference-count":192,"publisher":"Elsevier BV","issue":"8","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.metabol.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:16:19Z","timestamp":1448381779000},"page":"1062-1079","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Adipokines in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T21:28:22Z","timestamp":1567373302000},"score":1.0,"issued":{"date-parts":[[2016,8]]},"references-count":192,"journal-issue":{"published-print":{"date-parts":[[2016,8]]},"issue":"8"},"alternative-id":["S0026049515003510"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2015.11.006","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipokines in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T08:13:38Z","timestamp":1574756018310},"reference-count":24,"publisher":"Elsevier BV","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.mehy.2017.02.020","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T21:35:48Z","timestamp":1488836148000},"page":"33-36","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novel aspects of defensins\u2019 involvement in virus-induced autoimmunity in the central nervous system"],"prefix":"10.1016","volume":"102","author":[{"given":"Evangelos I.","family":"Kazakos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716303000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716303000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T20:53:11Z","timestamp":1536007991000},"score":1.0,"issued":{"date-parts":[[2017,5]]},"references-count":24,"alternative-id":["S0306987716303000"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2017.02.020","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel aspects of defensins\u2019 involvement in virus-induced autoimmunity in the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T14:05:30Z","timestamp":1574777130604},"reference-count":19,"publisher":"Wiley","issue":"12","license":[{"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor","start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"delay-in-days":0,"content-version":"vor"},{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obes Metab"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/dom.12989","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T07:46:42Z","timestamp":1493365602000},"page":"1805-1809","source":"Crossref","is-referenced-by-count":11,"title":["Effects of combined low\u2010dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non\u2010invasive indices of steatosis and fibrosis, and adipokine levels in non\u2010alcoholic fatty liver disease:\n            a\n            randomized controlled trial"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[{"name":"Second Medical Clinic, School of MedicineAristotle University of Thessaloniki Thessaloniki Greece"}]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, School of MedicineAristotle University of Thessaloniki Thessaloniki Greece"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and MetabolismBeth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts"}]},{"given":"Vaia","family":"Polymerou","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Biomedicine Laboratories Athens Greece"}]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, School of MedicineAristotle University of Thessaloniki Thessaloniki Greece"}]}],"member":"311","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"e_1_2_6_2_1","DOI":"10.1001\/jama.2015.5370","doi-asserted-by":"publisher"},{"key":"e_1_2_6_3_1","DOI":"10.1080\/14656566.2016.1225727","doi-asserted-by":"publisher"},{"key":"e_1_2_6_4_1","DOI":"10.1111\/j.1463-1326.2011.01403.x","doi-asserted-by":"publisher"},{"key":"e_1_2_6_5_1","DOI":"10.1111\/dom.12918","doi-asserted-by":"publisher"},{"key":"e_1_2_6_6_1","DOI":"10.1111\/dom.12809","doi-asserted-by":"publisher"},{"key":"e_1_2_6_7_1","DOI":"10.1097\/MCG.0b013e31824587e0","doi-asserted-by":"publisher"},{"key":"e_1_2_6_8_1","DOI":"10.1007\/s00125-016-3902-y","doi-asserted-by":"publisher"},{"key":"e_1_2_6_9_1","DOI":"10.1371\/journal.pone.0163069","doi-asserted-by":"publisher"},{"key":"e_1_2_6_10_1","DOI":"10.1111\/j.1463-1326.2009.01176.x","doi-asserted-by":"publisher"},{"key":"e_1_2_6_11_1","DOI":"10.1210\/en.2009-0869","doi-asserted-by":"publisher"},{"key":"e_1_2_6_12_1","DOI":"10.1016\/j.trsl.2006.03.007","doi-asserted-by":"publisher"},{"key":"e_1_2_6_13_1","DOI":"10.1152\/ajpendo.00419.2013","doi-asserted-by":"publisher"},{"key":"e_1_2_6_14_1","DOI":"10.1111\/liv.12794","doi-asserted-by":"publisher"},{"issue":"3","key":"e_1_2_6_15_1","first-page":"407","article-title":"Selective aldosterone blocker ameliorates the progression of non\u2010alcoholic steatohepatitis in rats","volume":"26","author":"Noguchi R","year":"2010","journal-title":"Int J Mol Med"},{"key":"e_1_2_6_16_1","DOI":"10.1007\/s11883-015-0541-6","doi-asserted-by":"publisher"},{"key":"e_1_2_6_17_1","DOI":"10.1111\/j.1572-0241.1999.01377.x","doi-asserted-by":"publisher"},{"key":"e_1_2_6_18_1","DOI":"10.1136\/bmj.c869","doi-asserted-by":"publisher"},{"key":"e_1_2_6_19_1","DOI":"10.1177\/1470320311402110","doi-asserted-by":"publisher"},{"key":"e_1_2_6_20_1","DOI":"10.1007\/s12020-015-0640-8","doi-asserted-by":"publisher"}],"container-title":["Diabetes, Obesity and Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12989","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.12989","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.12989","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.12989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T10:36:25Z","timestamp":1563532585000},"score":1.0,"issued":{"date-parts":[[2017,7,10]]},"references-count":19,"journal-issue":{"published-online":{"date-parts":[[2017,7,21]]},"published-print":{"date-parts":[[2017,12]]},"issue":"12"},"alternative-id":["10.1111\/dom.12989"],"URL":"http:\/\/dx.doi.org\/10.1111\/dom.12989","archive":["Portico"],"relation":{"cites":[]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T21:44:13Z","timestamp":1574804653045},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.metabol.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T16:19:20Z","timestamp":1464452360000},"page":"1297-1306","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:24:26Z","timestamp":1536683066000},"score":1.0,"issued":{"date-parts":[[2016,9]]},"references-count":53,"journal-issue":{"published-print":{"date-parts":[[2016,9]]},"issue":"9"},"alternative-id":["S0026049516300348"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2016.05.013","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:07:31Z","timestamp":1574813251218},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"delay-in-days":0,"content-version":"unspecified"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12020-017-1374-6","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T07:21:54Z","timestamp":1500535314000},"page":"376-387","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The intriguing connections of leptin to hyperparathyroidism"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Leonidas","family":"Duntas","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2015.973021","volume":"24","author":"SA Polyzos","year":"2015","unstructured":"S.A. Polyzos, P. Makras, Z. Efstathiadou, A.D. Anastasilakis, Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis. Exp. Opin. Investig. Drugs 24, 145\u2013157 (2015)","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"1374_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"W.D. Fraser, Hyperparathyroidism. Lancet 374, 145\u2013158 (2009)","journal-title":"Lancet"},{"key":"1374_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E. Young, L. Rejnmark, R. Thakker, P. D\u2019Amour, T. Paul, S. Van Uum, M.Z. Shrayyef, D. Goltzman, S. Kaiser, N.E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S.D. Rao, S.K. Bhadada, B.L. Clarke, J. Liu, Q. Duh, E.M. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S.J. Silverberg, R. Udelsman, K.S. Davison, J.T. Potts Jr., M.L. Brandi, J.P. Bilezikian, Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos. Int. 28, 1\u201319 (2017)","journal-title":"Osteoporos. Int."},{"key":"1374_CR4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","volume":"90","author":"MJ Bolland","year":"2005","unstructured":"M.J. Bolland, A.B. Grey, G.D. Gamble, I.R. Reid, Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J. Clin. Endocrinol. Metab. 90, 1525\u20131530 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR5","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1210\/jc.2010-0666","volume":"95","author":"MA Adam","year":"2010","unstructured":"M.A. Adam, B.R. Untch, M.E. Danko, S. Stinnett, D. Dixit, J. Koh, J.R. Marks, J.A. Olson Jr., Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95, 4917\u20134924 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.metabol.2014.10.017","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"S.A. Polyzos, C.S. Mantzoros, Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism 64, 5\u201312 (2015)","journal-title":"Metabolism"},{"key":"1374_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mehy.2010.08.039","volume":"76","author":"SP Cheng","year":"2011","unstructured":"S.P. Cheng, G.M. Doherty, Y.C. Chang, C.L. Liu, Leptin: the link between overweight and primary hyperparathyroidism? Med. Hypotheses 76, 94\u201396 (2011)","journal-title":"Med. Hypotheses"},{"key":"1374_CR8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2004.02101.x","volume":"61","author":"BE Wolfe","year":"2004","unstructured":"B.E. Wolfe, D.C. Jimerson, C. Orlova, C.S. Mantzoros, Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin. Endocrinol. 61, 332\u2013338 (2004)","journal-title":"Clin. Endocrinol."},{"key":"1374_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","volume":"18","author":"M Dalamaga","year":"2013","unstructured":"M. Dalamaga, S.H. Chou, K. Shields, P. Papageorgiou, S.A. Polyzos, C.S. Mantzoros, Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell. Metab. 18, 29\u201342 (2013)","journal-title":"Cell. Metab."},{"key":"1374_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MCG.0b013e3181ec5c66","volume":"45","author":"SA Polyzos","year":"2011","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, G. Deretzi, The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. J. Clin. Gastroenterol. 45, 50\u201354 (2011)","journal-title":"J. Clin. Gastroenterol."},{"key":"1374_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"S.A. Polyzos, J. Kountouras, C.S. Mantzoros, Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 64, 60\u201378 (2015)","journal-title":"Metabolism"},{"key":"1374_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.metabol.2014.07.017","volume":"64","author":"MA Tsoukas","year":"2015","unstructured":"M.A. Tsoukas, O.M. Farr, C.S. Mantzoros, Leptin in congenital and HIV-associated lipodystrophy. Metabolism 64, 47\u201359 (2015)","journal-title":"Metabolism"},{"key":"1374_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-016-1175-3","volume":"55","author":"M Karakose","year":"2017","unstructured":"M. Karakose, M. Caliskan, M.S. Arslan, T. Demirci, S. Karakose, E. Cakal, The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism. Endocrine 55, 283\u2013288 (2017)","journal-title":"Endocrine"},{"key":"1374_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1081\/JDI-65318","volume":"27","author":"D Sit","year":"2005","unstructured":"D. Sit, A.K. Kadiroglu, M.E. Yilmaz, I.H. Kara, B. Isikoglu, The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Ren. Fail. 27, 403\u2013407 (2005)","journal-title":"Ren. Fail."},{"key":"1374_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","volume":"34","author":"HS Moon","year":"2013","unstructured":"H.S. Moon, M. Dalamaga, S.Y. Kim, S.A. Polyzos, O.P. Hamnvik, F. Magkos, J. Paruthi, C.S. Mantzoros, Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr. Rev. 34, 377\u2013412 (2013)","journal-title":"Endocr. Rev."},{"key":"1374_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.metabol.2014.10.021","volume":"64","author":"J Upadhyay","year":"2015","unstructured":"J. Upadhyay, O.M. Farr, C.S. Mantzoros, The role of leptin in regulating bone metabolism. Metabolism 64, 105\u2013113 (2015)","journal-title":"Metabolism"},{"key":"1374_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00774-014-0569-7","volume":"33","author":"XX Chen","year":"2015","unstructured":"X.X. Chen, T. Yang, Roles of leptin in bone metabolism and bone diseases. J. Bone. Miner. Metab. 33, 474\u2013485 (2015)","journal-title":"J. Bone. Miner. Metab."},{"key":"1374_CR18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/en.2003-1010","volume":"145","author":"A Matsunuma","year":"2004","unstructured":"A. Matsunuma, T. Kawane, T. Maeda, S. Hamada, N. Horiuchi, Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob\/ob mice. Endocrinology 145, 1367\u20131375 (2004)","journal-title":"Endocrinology"},{"key":"1374_CR19","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jbmr.65","volume":"25","author":"K Tsuji","year":"2010","unstructured":"K. Tsuji, T. Maeda, T. Kawane, A. Matsunuma, N. Horiuchi, Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J. Bone. Miner. Res. 25, 1711\u20131723 (2010)","journal-title":"J. Bone. Miner. Res."},{"key":"1374_CR20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s12020-016-1207-z","volume":"56","author":"I Lopez","year":"2016","unstructured":"I. Lopez, C. Pineda, A.I. Raya, M.E. Rodriguez-Ortiz, J.M. Diaz-Tocados, R. Rios, J.M. Rodriguez, E. Aguilera-Tejero, Y. Almaden, Leptin directly stimulates parathyroid hormone secretion. Endocrine 56, 675\u2013678 (2016)","journal-title":"Endocrine"},{"key":"1374_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s12020-017-1308-3","volume":"56","author":"J George","year":"2017","unstructured":"J. George, The parathyroid leptin axis. Endocrine 56, 458\u2013459 (2017)","journal-title":"Endocrine"},{"key":"1374_CR22","unstructured":"D. Hoang, N. Broer, J.A. Sosa, N. Abitbol, X. Yao, F. Li, F. Rivera-Molina, D.K. Toomre, S.A. Roman, G. Sue, S. Kim, A.Y. Li, G.G. Callender, C. Simpson, D. Narayan, Leptin is produced by parathyroid glands and stimulates parathyroid hormone secretion. Ann. Surg. (2016). doi: 10.1097\/SLA.0000000000002004","DOI":"10.1097\/SLA.0000000000002004","doi-asserted-by":"publisher"},{"key":"1374_CR23","doi-asserted-by":"crossref","first-page":"27918","DOI":"10.1038\/srep27918","volume":"6","author":"Y Jiang","year":"2016","unstructured":"Y. Jiang, J. Zhang, Y. Yuan, X. Zha, C. Xing, C. Shen, Z. Shen, C. Qin, M. Zeng, G. Yang, H. Mao, B. Zhang, X. Yu, B. Sun, C. Ouyang, X. Xu, Y. Ge, J. Wang, L. Zhang, C. Cheng, C. Yin, J. Zhang, H. Chen, H. Ma, N. Wang, Association of increased serum leptin with ameliorated anemia and malnutrition in stage 5 chronic kidney disease patients after parathyroidectomy. Sci. Rep. 6, 27918 (2016)","journal-title":"Sci. Rep."},{"key":"1374_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","volume":"56","author":"E Delfini","year":"2007","unstructured":"E. Delfini, L. Petramala, C. Caliumi, D. Cotesta, G. De Toma, G. Cavallaro, G. Panzironi, D. Diacinti, S. Minisola, D.E. E, G.F. Mazzuoli, C. Letizia, Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56, 30\u201336 (2007)","journal-title":"Metabolism"},{"key":"1374_CR25","first-page":"890","volume":"52","author":"SK Bhadada","year":"2011","unstructured":"S.K. Bhadada, A. Bhansali, V.N. Shah, D.S. Rao, Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Singapore Med. J. 52, 890\u2013893 (2011)","journal-title":"Singapore Med. J."},{"key":"1374_CR26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcla.21541","volume":"26","author":"DA Luis de","year":"2012","unstructured":"D.A. de Luis, G.D. Soto, R. Conde, O. Izaola, B. de la Fuente, Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. J. Clin. Lab. Anal. 26, 398\u2013402 (2012)","journal-title":"J. Clin. Lab. Anal."},{"key":"1374_CR27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jamcollsurg.2013.11.013","volume":"218","author":"D Hoang","year":"2014","unstructured":"D. Hoang, N. Broer, S.A. Roman, X. Yao, N. Abitbol, F. Li, J.A. Sosa, G.R. Sue, A.T. DeWan, M.L. Wong, J. Licinio, C. Simpson, A.Y. Li, N. Pizzoferrato, D. Narayan, Leptin signaling and hyperparathyroidism: clinical and genetic associations. J. Am. Coll. Surg. 218, 1239\u20131250 (2014). e1234","journal-title":"J. Am. Coll. Surg."},{"key":"1374_CR28","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","volume":"94","author":"J Bollerslev","year":"2009","unstructured":"J. Bollerslev, T. Rosen, C.L. Mollerup, J. Nordenstrom, M. Baranowski, C. Franco, Y. Pernow, G.A. Isaksen, K. Godang, T. Ueland, S. Jansson, S.S. Group, Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94, 2255\u20132261 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000045462","volume":"82","author":"F Kokot","year":"1999","unstructured":"F. Kokot, J. Chudek, H. Karkoszka, M. Adamczak, A. Wiecek, D. Klimek, Does PTH influence leptin concentration in haemodialysed uraemic patients? Nephron 82, 372\u2013373 (1999)","journal-title":"Nephron"},{"key":"1374_CR30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2362.2002.01063.x","volume":"32","author":"R Pecoits-Filho","year":"2002","unstructured":"R. Pecoits-Filho, L. Nordfors, O. Heimburger, B. Lindholm, B. Anderstam, A. Marchlewska, P. Stenvinkel, Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur. J. Clin. Invest. 32, 811\u2013817 (2002)","journal-title":"Eur. J. Clin. Invest."},{"key":"1374_CR31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ajkd.2003.07.005","volume":"42","author":"G Coen","year":"2003","unstructured":"G. Coen, P. Ballanti, M.S. Fischer, A. Balducci, S. Calabria, L. Colamarco, G.Di Zazzo, F. Lifrieri, M. Manni, D. Sardella, I. Nofroni, E. Bonucci, Serum leptin in dialysis renal osteodystrophy. Am. J. Kidney Dis. 42, 1036\u20131042 (2003)","journal-title":"Am. J. Kidney Dis."},{"key":"1374_CR32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.ajkd.2005.06.004","volume":"46","author":"J Axelsson","year":"2005","unstructured":"J. Axelsson, A.R. Qureshi, O. Heimburger, B. Lindholm, P. Stenvinkel, P. Barany, Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am. J. Kidney Dis. 46, 628\u2013634 (2005)","journal-title":"Am. J. Kidney Dis."},{"key":"1374_CR33","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2215\/CJN.03520410","volume":"5","author":"CP Kovesdy","year":"2010","unstructured":"C.P. Kovesdy, M.Z. Molnar, M.E. Czira, A. Rudas, A. Ujszaszi, L. Rosivall, M. Szathmari, A. Covic, A. Keszei, G. Beko, P. Lakatos, J. Kosa, I. Mucsi, Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin. J. Am. Soc. Nephrol. 5, 2297\u20132304 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1374_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4314\/ajnt.v4i3.71030","volume":"4","author":"TA Ghonemy","year":"2011","unstructured":"T.A. Ghonemy, E.M. Salim, M. Atia, A. Fekry, K. Shawky, Serum leptin and bone mineral density in hemodialysis patients with or without liver diseases. Arab J. Nephrol. Transplant. 4, 131\u2013136 (2011)","journal-title":"Arab J. Nephrol. Transplant."},{"key":"1374_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11255-012-0308-8","volume":"45","author":"O Ulutas","year":"2013","unstructured":"O. Ulutas, H. Taskapan, M.C. Taskapan, I. Temel, Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int. Urol. Nephrol. 45, 879\u2013884 (2013)","journal-title":"Int. Urol. Nephrol."},{"key":"1374_CR36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000449018","volume":"44","author":"Y Jiang","year":"2016","unstructured":"Y. Jiang, Z. Shen, J. Zhang, C. Xing, X. Zha, C. Shen, M. Zeng, G. Yang, H. Mao, B. Zhang, X. Yu, B. Sun, C. Ouyang, Y. Ge, L. Zhang, C. Cheng, J. Zhang, C. Yin, H. Chen, N. Wang, Parathyroidectomy increases heart rate variability and leptin levels in patients with stage 5 chronic kidney disease. Am. J. Nephrol. 44, 245\u2013254 (2016)","journal-title":"Am. J. Nephrol."},{"key":"1374_CR37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfu120","volume":"8","author":"AC Baxmann","year":"2015","unstructured":"A.C. Baxmann, V.B. Menon, J.O. Medina-Pestana, A.B. Carvalho, I.P. Heilberg, Overweight and body fat are predictors of hypovitaminosis D in renal transplant patients. Clin. Kidney J. 8, 49\u201353 (2015)","journal-title":"Clin. Kidney J."},{"key":"1374_CR38","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.transproceed.2015.06.002","volume":"47","author":"JP Tsai","year":"2015","unstructured":"J.P. Tsai, M.C. Lee, Y.C. Chen, G.J. Ho, M.H. Shih, B.G. Hsu, Hyperleptinemia is a risk factor for the development of central arterial stiffness in kidney transplant patients. Transplant. Proc. 47, 1825\u20131830 (2015)","journal-title":"Transplant. Proc."},{"key":"1374_CR39","first-page":"148","volume":"122","author":"T Hryszko","year":"2012","unstructured":"T. Hryszko, S. Brzosko, A. Rydzewska-Rosolowska, E. Koc-Zorawska, B. Naumnik, M. Mysliwiec, Effect of secondary hyperparathyroidism treatment with cinacalcet on selected adipokines and markers of endothelial injury in hemodialysis patients: a preliminary report. Pol. Arch. Med. Wewn. 122, 148\u2013153 (2012)","journal-title":"Pol. Arch. Med. Wewn."},{"key":"1374_CR40","first-page":"73","volume":"32","author":"A Polymeris","year":"2012","unstructured":"A. Polymeris, K. Doumouchtsis, E. Grapsa, Bone mineral density and bone metabolism in hemodialysis patients. Correlation with PTH, 25OHD3 and leptin. Nefrologia 32, 73\u201378 (2012)","journal-title":"Nefrologia"},{"key":"1374_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1319-2442.106238","volume":"24","author":"F Ahmadi","year":"2013","unstructured":"F. Ahmadi, S. Salari, S. Maziar, F. Esfahanian, Z. Khazaeipour, N. Ranjbarnovin, Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis. Saudi J. Kidney. Dis. Transpl. 24, 41\u201347 (2013)","journal-title":"Saudi J. Kidney. Dis. Transpl."},{"key":"1374_CR42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15171\/jrip.2016.24","volume":"5","author":"M Ghorban-Sabbagh","year":"2016","unstructured":"M. Ghorban-Sabbagh, F. Nazemian, M. Naghibi, M.T. Shakeri, S. Ahmadi-Simab, R. Javidi-Dasht-Bayaz, Correlation between serum leptin and bone mineral density in hemodialysis patients. J. Renal. Inj. Prev. 5, 112\u2013117 (2016)","journal-title":"J. Renal. Inj. Prev."},{"key":"1374_CR43","first-page":"253","volume":"17","author":"C Zoccali","year":"2004","unstructured":"C. Zoccali, V. Panuccio, G. Tripepi, S. Cutrupi, P. Pizzini, F. Mallamaci, Leptin and biochemical markers of bone turnover in dialysis patients. J. Nephrol. 17, 253\u2013260 (2004)","journal-title":"J. Nephrol."},{"key":"1374_CR44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"S.A. Polyzos, C.S. Mantzoros, Nonalcoholic fatty future disease. Metabolism 65, 1007\u20131016 (2016)","journal-title":"Metabolism"},{"key":"1374_CR45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","volume":"59","author":"SA Polyzos","year":"2016","unstructured":"S.A. Polyzos, K.N. Aronis, J. Kountouras, D.D. Raptis, M.F. Vasiloglou, C.S. Mantzoros, Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia 59, 30\u201343 (2016)","journal-title":"Diabetologia"},{"key":"1374_CR46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cca.2015.02.040","volume":"444","author":"K Liu","year":"2015","unstructured":"K. Liu, P. Liu, R. Liu, X. Wu, M. Cai, Relationship between serum leptin levels and bone mineral density: a systematic review and meta-analysis. Clin. Chim. Acta. 444, 260\u2013263 (2015)","journal-title":"Clin. Chim. Acta."},{"key":"1374_CR47","unstructured":"S.A. Polyzos, J. Kountouras, C.S. Mantzoros, Adipose tissue, obesity and nonalcoholic fatty liver disease. Minerva Endocrinol. (2016) [epub ahead of print]","DOI":"10.1016\/j.metabol.2015.11.006","doi-asserted-by":"crossref"},{"key":"1374_CR48","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","volume":"6","author":"G Thomas","year":"2011","unstructured":"G. Thomas, A.R. Sehgal, S.R. Kashyap, T.R. Srinivas, J.P. Kirwan, S.D. Navaneethan, Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 6, 2364\u20132373 (2011)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1374_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14310\/horm.2002.1308","volume":"10","author":"KA Toulis","year":"2011","unstructured":"K.A. Toulis, A.D. Anastasilakis, S.A. Polyzos, P. Makras, Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis. Hormones 10, 174\u2013195 (2011)","journal-title":"Hormones"},{"key":"1374_CR50","first-page":"172","volume":"7","author":"EG Abate","year":"2016","unstructured":"E.G. Abate, B.L. Clarke, Review of Hypoparathyroidism. Front. Endocrinol. 7, 172 (2016)","journal-title":"Front. Endocrinol."},{"key":"1374_CR51","doi-asserted-by":"crossref","first-page":"E2252","DOI":"10.1210\/jc.2014-2491","volume":"99","author":"JP Foo","year":"2014","unstructured":"J.P. Foo, S.A. Polyzos, A.D. Anastasilakis, S. Chou, C.S. Mantzoros, The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 99, E2252\u2013E2258 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR52","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","volume":"99","author":"JD Christensen","year":"2014","unstructured":"J.D. Christensen, A.O. Lungu, E. Cochran, M.T. Collins, R.I. Gafni, J.C. Reynolds, K.I. Rother, P. Gorden, R.J. Brown, Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy. J. Clin. Endocrinol. Metab. 99, E1493\u2013E1500 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR53","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1210\/jc.2015-1477","volume":"100","author":"T Harslof","year":"2015","unstructured":"T. Harslof, T. Sikjaer, L. Sorensen, S.B. Pedersen, L. Mosekilde, B.L. Langdahl, L. Rejnmark, The effect of treatment with pth on undercarboxylated osteocalcin and energy metabolism in hypoparathyroidism. J. Clin. Endocrinol. Metab. 100, 2758\u20132762 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR54","doi-asserted-by":"crossref","first-page":"E1982","DOI":"10.1210\/jc.2011-0587","volume":"96","author":"AL Schafer","year":"2011","unstructured":"A.L. Schafer, D.E. Sellmeyer, A.V. Schwartz, C.J. Rosen, E. Vittinghoff, L. Palermo, J.P. Bilezikian, D.M. Shoback, D.M. Black, Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J. Clin. Endocrinol. Metab. 96, E1982\u2013E1989 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1374_CR55","first-page":"931","volume":"29","author":"E Passeri","year":"2015","unstructured":"E. Passeri, E. Dozio, M. Mendola, E. Costa, F. Bandera, M.M. Corsi Romanelli, S. Corbetta, Treatment with teriparatide might be associated with cardiometabolic changes in postmenopausal severe osteoporotic women. J. Biol. Regul. Homeost. Agents 29, 931\u2013940 (2015)","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"1374_CR56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/01635580802455149","volume":"61","author":"M Maetani","year":"2009","unstructured":"M. Maetani, G. Maskarinec, A.A. Franke, R.V. Cooney, Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr. Cancer 61, 225\u2013231 (2009)","journal-title":"Nutr. Cancer"}],"container-title":["Endocrine"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1374-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T02:36:14Z","timestamp":1569897374000},"score":1.0,"issued":{"date-parts":[[2017,7,20]]},"references-count":56,"journal-issue":{"published-print":{"date-parts":[[2017,9]]},"issue":"3"},"alternative-id":["1374"],"URL":"http:\/\/dx.doi.org\/10.1007\/s12020-017-1374-6","relation":{"cites":[]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T02:45:03Z","timestamp":1574822703915},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.metabol.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T12:37:19Z","timestamp":1469536639000},"page":"1550-1558","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Activin A and follistatin in patients with nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Georgios \u0391.","family":"Triantafyllou","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T07:25:34Z","timestamp":1536564334000},"score":1.0,"issued":{"date-parts":[[2016,10]]},"references-count":29,"journal-issue":{"published-print":{"date-parts":[[2016,10]]},"issue":"10"},"alternative-id":["S0026049516300737"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2016.07.009","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin A and follistatin in patients with nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T04:14:07Z","timestamp":1574828047767},"reference-count":47,"publisher":"Elsevier BV","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.metabol.2016.08.001","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:50:01Z","timestamp":1470790201000},"page":"64-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-\u03b3 agonists"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T10:24:33Z","timestamp":1568283873000},"score":1.0,"issued":{"date-parts":[[2017,1]]},"references-count":47,"alternative-id":["S0026049516300890"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2016.08.001","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-\u03b3 agonists","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T13:48:39Z","timestamp":1574862519000},"reference-count":79,"publisher":"Elsevier BV","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.metabol.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T06:48:13Z","timestamp":1511419693000},"page":"15-26","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Juvenile Paget disease"],"prefix":"10.1016","volume":"80","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Tim","family":"Cundy","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517302810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517302810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T17:20:48Z","timestamp":1570382448000},"score":1.0,"issued":{"date-parts":[[2018,3]]},"references-count":79,"alternative-id":["S0026049517302810"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2017.10.007","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile Paget disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T13:24:21Z","timestamp":1574861061535},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12020-018-1699-9","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T05:12:45Z","timestamp":1533273165000},"page":"487-489","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"1699_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/TCRM.S24239","volume":"8","author":"AD Anastasilakis","year":"2012","unstructured":"A.D. Anastasilakis, K.A. Toulis, S.A. Polyzos, C.D. Anastasilakis, P. Makras, Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther. Clin. Risk Manag. 8, 295\u2013306 (2012)","journal-title":"Ther. Clin. Risk Manag."},{"key":"1699_CR2","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/EJE-18-0056","volume":"179","author":"AD Anastasilakis","year":"2018","unstructured":"A.D. Anastasilakis, S.A. Polyzos, P. Makras, Therapy of endocrine disease: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis. Eur. J. Endocrinol. 179, R31\u2013r45 (2018)","journal-title":"Eur. J. Endocrinol."},{"key":"1699_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10067-014-2562-x","volume":"33","author":"GS Breuer","year":"2014","unstructured":"G.S. Breuer, M. Ehrenfeld, I. Rosner, A. Balbir-Gurman, D. Zisman, S. Oren, D. Paran, Late-onset neutropenia following rituximab treatment for rheumatologic conditions. Clin. Rheumatol. 33, 1337\u20131340 (2014)","journal-title":"Clin. Rheumatol."}],"container-title":["Endocrine"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1699-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1699-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1699-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T07:06:54Z","timestamp":1565161614000},"score":1.0,"issued":{"date-parts":[[2018,8,3]]},"references-count":3,"journal-issue":{"published-print":{"date-parts":[[2018,11]]},"issue":"2"},"alternative-id":["1699"],"URL":"http:\/\/dx.doi.org\/10.1007\/s12020-018-1699-9","relation":{"cites":[]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S.A.P. has received a lecture fee from AMGEN. E.T. has received lectures fees, research grants from AMGEN and is a member of the steering committee of AMGEN.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol received an exemption from the ethics committee of Medical School of Aristotle University of Thessaloniki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]},{"indexed":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T16:13:25Z","timestamp":1575216805569},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.mehy.2013.03.040","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T17:07:12Z","timestamp":1367341632000},"page":"147","source":"Crossref","is-referenced-by-count":3,"title":["Is Helicobacter pylori the usual suspect behind gastroesophageal reflux disease and dacryostenosis?"],"prefix":"10.1016","volume":"81","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Iordanis","family":"Romiopoulos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Tsiaousi","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Evangelia","family":"Giartza-Taxidou","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Vardaka","sequence":"additional","affiliation":[]},{"given":"Efimia","family":"Loli","sequence":"additional","affiliation":[]},{"given":"Constantinos","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T11:54:33Z","timestamp":1539690873000},"score":1.0,"issued":{"date-parts":[[2013,7]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2013,7]]},"issue":"1"},"alternative-id":["S0306987713001643"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2013.03.040","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":["General Medicine"]},{"indexed":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T07:46:52Z","timestamp":1575272812661},"reference-count":5,"publisher":"Wiley","issue":"1","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"delay-in-days":0,"content-version":"tdm"},{"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor","start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"delay-in-days":4,"content-version":"vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1002\/hep.29897","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T15:02:07Z","timestamp":1522422127000},"page":"389-389","source":"Crossref","is-referenced-by-count":11,"title":["Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?"],"prefix":"10.1002","volume":"68","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[{"name":"First Department of Pharmacology, Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece"}]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, School of Medicine; Aristotle University of Thessaloniki; Thessaloniki Greece"}]},{"given":"Sotiris","family":"Anastasiadis","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, School of Medicine; Aristotle University of Thessaloniki; Thessaloniki Greece"}]},{"given":"Michael","family":"Doulberis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; B\u00fcrgerspital Hospital; Solothurn Switzerland"}]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[{"name":"Second Medical Clinic, School of Medicine; Aristotle University of Thessaloniki; Thessaloniki Greece"}]}],"member":"311","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"10.1002\/hep.29897-BIB0001|hep29897-cit-0001","author":"Younossi","year":"2017","article-title":"Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)","journal-title":"Hepatology","DOI":"10.1002\/hep.29724","doi-asserted-by":"publisher"},{"key":"10.1002\/hep.29897-BIB0002|hep29897-cit-0002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","article-title":"Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease","volume":"46","author":"Polyzos","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1002\/hep.29897-BIB0003|hep29897-cit-0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2010.310","article-title":"Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required?","volume":"106","author":"Arendt","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/hep.29897-BIB0004|hep29897-cit-0004","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/dom.12989","article-title":"Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"19","author":"Polyzos","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1002\/hep.29897-BIB0005|hep29897-cit-0005","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1080\/14656566.2016.1225727","article-title":"Emerging and future therapies for nonalcoholic steatohepatitis in adults","volume":"17","author":"Mintziori","year":"2016","journal-title":"Expert Opin Pharmacother"}],"container-title":["Hepatology"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.29897","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/hep.29897\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T12:28:50Z","timestamp":1541766530000},"score":1.0,"issued":{"date-parts":[[2018,7]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2018,7]]},"issue":"1"},"URL":"http:\/\/dx.doi.org\/10.1002\/hep.29897","archive":["Portico"],"relation":{"cites":[]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":["Hepatology"]},{"indexed":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:16:01Z","timestamp":1575285361700},"reference-count":11,"publisher":"The American Association of Immunologists","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J.I."],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.4049\/jimmunol.1800155","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T20:35:24Z","timestamp":1524515724000},"page":"3027.1-3027","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cTherapeutic Application of an Extract of Helicobacter pylori Ameliorates the Development of Allergic Airway Disease\u201d"],"prefix":"10.4049","volume":"200","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0002-0396-5081","authenticated-orcid":false,"given":"Michael","family":"Doulberis","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]},{"ORCID":"http:\/\/orcid.org\/0000-0002-9693-3846","authenticated-orcid":false,"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]}],"member":"2487","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"2019061914325654000_200.9.3027.1","DOI":"10.4049\/jimmunol.1700987","doi-asserted-by":"publisher"},{"key":"2019061914325654000_200.9.3027.2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijms.4970","article-title":"Is Helicobacter pylori infection associated with asthma risk? A meta-analysis based on 770 cases and 785 controls","volume":"9","author":"Wang","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"2019061914325654000_200.9.3027.3","DOI":"10.1111\/hel.12012","doi-asserted-by":"publisher"},{"key":"2019061914325654000_200.9.3027.4","DOI":"10.1086\/597066","doi-asserted-by":"publisher"},{"key":"2019061914325654000_200.9.3027.5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s10096-017-2972-1","article-title":"Helicobacter pylori infection increases the risk of adult-onset asthma: a nationwide cohort study","volume":"36","author":"Wang","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"2019061914325654000_200.9.3027.6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/apt.13572","article-title":"Helicobacter pylori in children with asthmatic conditions at school age, and their mothers","volume":"43","author":"den Hollander","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2019061914325654000_200.9.3027.7","DOI":"10.1111\/hel.12058","doi-asserted-by":"publisher"},{"key":"2019061914325654000_200.9.3027.8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.cgh.2015.02.009","article-title":"Helicobacter pylori associated with obstructive sleep apnea might contribute to sleep, cognition, and driving performance disturbances in patients with cirrhosis","volume":"13","author":"Kountouras","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2019061914325654000_200.9.3027.9","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4103\/0366-6999.213428","article-title":"Characteristics of proinflammatory cytokines and chemokines in airways of asthmatics: relationships with disease severity and infiltration of inflammatory cells","volume":"130","author":"Yang","year":"2017","journal-title":"Chin. Med. J. (Engl.)"},{"key":"2019061914325654000_200.9.3027.10","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.21037\/jtd.2017.01.05","article-title":"Recent developments in the role of reactive oxygen species in allergic asthma","volume":"9","author":"Qu","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"2019061914325654000_200.9.3027.11","unstructured":"Kong, D. L. Z. Qin H. Shen H. Y. Jin W. Wang Z. F. Wang . 2017. Association of obstructive sleep apnea with asthma: a meta-analysis. Sci. Rep. DOI: 10.1038s41598-017-04446-6."}],"container-title":["The Journal of Immunology"],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.4049\/jimmunol.1800155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T22:33:51Z","timestamp":1560983631000},"score":1.0,"issued":{"date-parts":[[2018,4,23]]},"references-count":11,"journal-issue":{"published-online":{"date-parts":[[2018,4,23]]},"published-print":{"date-parts":[[2018,5,1]]},"issue":"9"},"alternative-id":["10.4049\/jimmunol.1800155"],"URL":"http:\/\/dx.doi.org\/10.4049\/jimmunol.1800155","relation":{"cites":[]},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":["Immunology"]},{"indexed":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T07:00:31Z","timestamp":1575356431382},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s42000-018-0083-8","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T21:57:02Z","timestamp":1542923822000},"page":"573-579","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[]},{"given":"Gerhard","family":"Hawa","sequence":"additional","affiliation":[]},{"given":"Linda","family":"Sonnleitner","sequence":"additional","affiliation":[]},{"given":"Albert","family":"Missbichler","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Doulberis","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"issue":"8","key":"83_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"Polyzos SA, Mantzoros CS (2016) Nonalcoholic fatty future disease. Metabolism 65(8):1007\u20131016. \n                    https:\/\/doi.org\/10.1016\/j.metabol.2015.12.009","journal-title":"Metabolism"},{"issue":"14","key":"83_CR2","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1080\/14656566.2016.1225727","volume":"17","author":"G Mintziori","year":"2016","unstructured":"Mintziori G, Polyzos SA (2016) Emerging and future therapies for nonalcoholic steatohepatitis in adults. Expert Opin Pharmacother 17(14):1937\u20131946. \n                    https:\/\/doi.org\/10.1080\/14656566.2016.1225727","journal-title":"Expert Opin Pharmacother"},{"key":"83_CR3","doi-asserted-by":"publisher","first-page":"2784537","DOI":"10.1155\/2018\/2784537","volume":"2018","author":"B Li","year":"2018","unstructured":"Li B, Zhang C, Zhan YT (2018) Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol 2018:2784537. \n                    https:\/\/doi.org\/10.1155\/2018\/2784537","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"83_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"EASL\u2013EASD\u2013EASO","year":"2016","unstructured":"EASL\u2013EASD\u2013EASO (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59(6):1121\u20131140. \n                    https:\/\/doi.org\/10.1007\/s00125-016-3902-y","journal-title":"Diabetologia"},{"issue":"12","key":"83_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/dom.12989","volume":"19","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS, Polymerou V, Katsinelos P (2017) Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. Diabetes Obes Metab 19(12):1805\u20131809. \n                    https:\/\/doi.org\/10.1111\/dom.12989","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"83_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1470320311402110","volume":"12","author":"SA Polyzos","year":"2011","unstructured":"Polyzos SA, Kountouras J, Zafeiriadou E, Patsiaoura K, Katsiki E, Deretzi G, Zavos C, Tsarouchas G, Rakitzi P, Slavakis A (2011) Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. J Renin-Angiotensin-Aldosterone Syst 12(4):498\u2013503. \n                    https:\/\/doi.org\/10.1177\/1470320311402110","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"4","key":"83_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biocel.2011.01.007","volume":"43","author":"C Krause","year":"2011","unstructured":"Krause C, Guzman A, Knaus P (2011) Noggin. Int J Biochem Cell Biol 43(4):478\u2013481. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2011.01.007","journal-title":"Int J Biochem Cell Biol"},{"key":"83_CR8","doi-asserted-by":"publisher","first-page":"31949","DOI":"10.1038\/srep31949","volume":"6","author":"D Costamagna","year":"2016","unstructured":"Costamagna D, Mommaerts H, Sampaolesi M, Tylzanowski P (2016) Noggin inactivation affects the number and differentiation potential of muscle progenitor cells in vivo. Sci Rep 6:31949. \n                    https:\/\/doi.org\/10.1038\/srep31949","journal-title":"Sci Rep"},{"key":"83_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-nutr-071813-105646","volume":"34","author":"NL Parrow","year":"2014","unstructured":"Parrow NL, Fleming RE (2014) Bone morphogenetic proteins as regulators of iron metabolism. Annu Rev Nutr 34:77\u201394. \n                    https:\/\/doi.org\/10.1146\/annurev-nutr-071813-105646","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"83_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"72","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72(3):299\u2013314","journal-title":"Curr Mol Med"},{"issue":"3","key":"83_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00535-016-1237-6","volume":"52","author":"T Hasebe","year":"2017","unstructured":"Hasebe T, Tanaka H, Sawada K, Nakajima S, Ohtake T, Fujiya M, Kohgo Y (2017) Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model. J Gastroenterol 52(3):341\u2013351. \n                    https:\/\/doi.org\/10.1007\/s00535-016-1237-6","journal-title":"J Gastroenterol"},{"issue":"1","key":"83_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12072-017-9841-y","volume":"12","author":"P Chen","year":"2018","unstructured":"Chen P, Luo Q, Huang C, Gao Q, Li L, Chen J, Chen B, Liu W, Zeng W, Chen Z (2018) Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. Hepatol Int 12(1):26\u201336. \n                    https:\/\/doi.org\/10.1007\/s12072-017-9841-y","journal-title":"Hepatol Int"},{"issue":"8","key":"83_CR13","doi-asserted-by":"publisher","first-page":"e0182932","DOI":"10.1371\/journal.pone.0182932","volume":"12","author":"KJ Belongie","year":"2017","unstructured":"Belongie KJ, Ferrannini E, Johnson K, Andrade-Gordon P, Hansen MK, Petrie JR (2017) Identification of novel biomarkers to monitor beta-cell function and enable early detection of type 2 diabetes risk. PLoS One 12(8):e0182932. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0182932","journal-title":"PLoS One"},{"issue":"2","key":"83_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s42000-018-0041-5","volume":"17","author":"BS Yurekli","year":"2018","unstructured":"Yurekli BS, Kocabas GU, Aksit M, Kutbay NO, Suner A, Yurekli I, Cakir H, Bozkaya G, Cetinkalp S (2018) The low levels of bone morphogenic protein-4 and its antagonist noggin in type 2 diabetes. Hormones (Athens) 17(2):247\u2013253. \n                    https:\/\/doi.org\/10.1007\/s42000-018-0041-5","journal-title":"Hormones (Athens)"},{"issue":"4","key":"83_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2012) Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 46(4):272\u2013284. \n                    https:\/\/doi.org\/10.1097\/MCG.0b013e31824587e0","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"83_CR16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1665-2681(19)31316-X","volume":"12","author":"S Polyzos","year":"2013","unstructured":"Polyzos S, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Zavos C, Papadopoulou E, Terpos E (2013) Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease - introduction of CHA index. Ann Hepatol 12(5):749\u2013757","journal-title":"Ann Hepatol"},{"key":"83_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ab.2018.03.002","volume":"549","author":"G Hawa","year":"2018","unstructured":"Hawa G, Sonnleitner L, Missbichler A, Prinz A, Bauer G, Mauracher C (2018) Single step, direct fluorescence immunoassays based on metal enhanced fluorescence (MEF-FIA) applicable as micro plate-, array-, multiplexing- or point of care-format. Anal Biochem 549:39\u201344. \n                    https:\/\/doi.org\/10.1016\/j.ab.2018.03.002","journal-title":"Anal Biochem"},{"issue":"6","key":"83_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313\u20131321","journal-title":"Hepatology"},{"issue":"15","key":"83_CR19","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1074\/jbc.M111.293613","volume":"287","author":"A Sawant","year":"2012","unstructured":"Sawant A, Chanda D, Isayeva T, Tsuladze G, Garvey WT, Ponnazhagan S (2012) Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity. J Biol Chem 287(15):12241\u201312249. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.293613","journal-title":"J Biol Chem"},{"issue":"5","key":"83_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2337\/db11-1419","volume":"61","author":"B Gustafson","year":"2012","unstructured":"Gustafson B, Smith U (2012) The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 61(5):1217\u20131224. \n                    https:\/\/doi.org\/10.2337\/db11-1419","journal-title":"Diabetes"},{"issue":"6326","key":"83_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1126\/science.aai8792","volume":"355","author":"MV Plikus","year":"2017","unstructured":"Plikus MV, Guerrero-Juarez CF, Ito M, Li YR, Dedhia PH, Zheng Y, Shao M, Gay DL, Ramos R, Hsi TC, Oh JW, Wang X, Ramirez A, Konopelski SE, Elzein A, Wang A, Supapannachart RJ, Lee HL, Lim CH, Nace A, Guo A, Treffeisen E, Andl T, Ramirez RN, Murad R, Offermanns S, Metzger D, Chambon P, Widgerow AD, Tuan TL, Mortazavi A, Gupta RK, Hamilton BA, Millar SE, Seale P, Pear WS, Lazar MA, Cotsarelis G (2017) Regeneration of fat cells from myofibroblasts during wound healing. Science 355(6326):748\u2013752. \n                    https:\/\/doi.org\/10.1126\/science.aai8792","journal-title":"Science"},{"issue":"5","key":"83_CR22","doi-asserted-by":"publisher","first-page":"H747","DOI":"10.1152\/ajpheart.00825.2012","volume":"305","author":"M Koga","year":"2013","unstructured":"Koga M, Engberding N, Dikalova AE, Chang KH, Seidel-Rogol B, Long JS, Lassegue B, Jo H, Griendling KK (2013) The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db\/db mice. Am J Physiol Heart Circ Physiol 305(5):H747\u2013H755. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00825.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"83_CR23","first-page":"1137","volume":"18","author":"W Zhang","year":"2015","unstructured":"Zhang W, Yu Z, Deng F (2015) The role of noggin in regulation of high glucose-induced apoptosis and insulin secretion in INS-1 rat beta cells. Iran J Basic Med Sci 18(11):1137\u20131142","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"83_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1210\/me.2014-1313","volume":"29","author":"JY Youn","year":"2015","unstructured":"Youn JY, Zhou J, Cai H (2015) Bone morphogenic protein 4 mediates NOX1-dependent eNOS uncoupling, endothelial dysfunction, and COX2 induction in type 2 diabetes mellitus. Mol Endocrinol 29(8):1123\u20131133. \n                    https:\/\/doi.org\/10.1210\/me.2014-1313","journal-title":"Mol Endocrinol"},{"issue":"1","key":"83_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/atvbaha.113.302696","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Liu J, Tian XY, Wong WT, Chen Y, Wang L, Luo J, Cheang WS, Lau CW, Kwan KM, Wang N, Yao X, Huang Y (2014) Inhibition of bone morphogenic protein 4 restores endothelial function in db\/db diabetic mice. Arterioscler Thromb Vasc Biol 34(1):152\u2013159. \n                    https:\/\/doi.org\/10.1161\/atvbaha.113.302696","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"83_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/dbio.2002.0779","volume":"250","author":"W Balemans","year":"2002","unstructured":"Balemans W, Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250(2):231\u2013250","journal-title":"Dev Biol"},{"issue":"24","key":"83_CR27","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.106.611822","volume":"113","author":"S Miriyala","year":"2006","unstructured":"Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, Jo H (2006) Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113(24):2818\u20132825. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.611822","journal-title":"Circulation"},{"issue":"4","key":"83_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.athoracsur.2012.12.028","volume":"95","author":"J Hu","year":"2013","unstructured":"Hu J, Liu J, Kwok MW, Wong RH, Huang Y, Wan S (2013) Bone morphogenic protein-4 contributes to venous endothelial dysfunction in patients with diabetes undergoing coronary revascularization. Ann Thorac Surg 95(4):1331\u20131339. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2012.12.028","journal-title":"Ann Thorac Surg"},{"key":"83_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.gene.2017.06.051","volume":"627","author":"V Olsavszky","year":"2017","unstructured":"Olsavszky V, Ulbrich F, Singh S, Diett M, Sticht C, Schmid CD, Zierow J, Wohlfeil SA, Schledzewski K, Dooley S, Gaitantzi H, Breitkopf-Heinlein K, Geraud C, Goerdt S, Koch PS (2017) GATA4 and LMO3 balance angiocrine signaling and autocrine inflammatory activation by BMP2 in liver sinusoidal endothelial cells. Gene 627:491\u2013499. \n                    https:\/\/doi.org\/10.1016\/j.gene.2017.06.051","journal-title":"Gene"},{"issue":"6","key":"83_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1159\/000350116","volume":"31","author":"S Wang","year":"2013","unstructured":"Wang S, Zhou G, Shu G, Wang L, Zhu X, Gao P, Xi Q, Zhang Y, Yuan L, Jiang Q (2013) Glucose utilization, lipid metabolism and BMP-Smad signaling pathway of porcine intramuscular preadipocytes compared with subcutaneous preadipocytes. Cell Physiol Biochem 31(6):981\u2013996. \n                    https:\/\/doi.org\/10.1159\/000350116","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"83_CR31","first-page":"127","volume":"13","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease. Hippokratia 13(2):127","journal-title":"Hippokratia"},{"issue":"1","key":"83_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.29897","volume":"68","author":"SA Polyzos","year":"2018","unstructured":"Polyzos SA, Kountouras J, Anastasiadis S, Doulberis M, Katsinelos P (2018) Nonalcoholic fatty liver disease: is it time for combination treatment and a diabetes-like approach? Hepatology 68(1):389. \n                    https:\/\/doi.org\/10.1002\/hep.29897","journal-title":"Hepatology"},{"issue":"1","key":"83_CR33","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3390\/antiox7010012","volume":"7","author":"H Hadi El","year":"2018","unstructured":"El Hadi H, Vettor R, Rossato M (2018) Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth? Antioxidants (Basel) 7(1):E12. \n                    https:\/\/doi.org\/10.3390\/antiox7010012","journal-title":"Antioxidants (Basel)"}],"container-title":["Hormones"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0083-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:23:20Z","timestamp":1574382200000},"score":1.0,"issued":{"date-parts":[[2018,11,22]]},"references-count":33,"journal-issue":{"published-print":{"date-parts":[[2018,12]]},"issue":"4"},"alternative-id":["83"],"URL":"http:\/\/dx.doi.org\/10.1007\/s42000-018-0083-8","relation":{"cites":[]},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":["Endocrinology, Diabetes and Metabolism","General Medicine"],"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided informed consent at baseline. The study protocol was in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Medical School, Aristotle University of Thessaloniki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"G. Hawa, L. Sonnleitner, and A. Missbichler are employees of FIANOSTICS GmbH, Wiener Neustadt, Austria. All other authors have no potential conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]},{"indexed":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T21:18:35Z","timestamp":1575407915787},"reference-count":8,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Scandinavian Journal of Gastroenterology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.3109\/00365521.2013.869351","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T09:11:32Z","timestamp":1386148292000},"page":"381-382","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["ActiveHelicobacter pyloriinfection is associated with colorectal mucosa \u2013 adenomatous polyp \u2013 early and advanced adenocarcinoma sequence"],"prefix":"10.3109","volume":"49","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Nikolaos","family":"Kapetanakis","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"George","family":"Kouklakis","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Venizelos","sequence":"additional","affiliation":[]},{"given":"Christina","family":"Nikolaidou","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Tzilves","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Paikos","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Giouleme","sequence":"additional","affiliation":[]},{"given":"Konstantinos","family":"Soufleris","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"key":"CIT0001","author":"Shmuely H","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"CIT0002","author":"Pilpilidis I","volume":"166","first-page":"255","year":"2011","journal-title":"J Surg Res","DOI":"10.1016\/j.jss.2010.02.012","doi-asserted-by":"crossref"},{"key":"CIT0003","author":"Kapetanakis N","volume":"176","first-page":"566","year":"2012","journal-title":"Am J Epidemiol","DOI":"10.1093\/aje\/kws302","doi-asserted-by":"crossref"},{"key":"CIT0004","author":"Zhang Y","volume":"175","first-page":"441","year":"2012","journal-title":"Am J Epidemiol","DOI":"10.1093\/aje\/kwr331","doi-asserted-by":"crossref"},{"key":"CIT0005","author":"Hong SN","volume":"57","first-page":"2184","year":"2012","journal-title":"Dig Dis Sci","DOI":"10.1007\/s10620-012-2245-x","doi-asserted-by":"crossref"},{"key":"CIT0006","author":"Kapetanakis N","volume":"2","first-page":"47","year":"2013","journal-title":"Immunogastroenterology","DOI":"10.7178\/ig.24","doi-asserted-by":"crossref"},{"key":"CIT0007","author":"Kountouras J","volume":"108","first-page":"625","year":"2013","journal-title":"Am J Gastroenterol","DOI":"10.1038\/ajg.2013.17","doi-asserted-by":"crossref"},{"key":"CIT0008","author":"Kountouras J","volume":"146","first-page":"149","year":"2008","journal-title":"J Surg Res","DOI":"10.1016\/j.jss.2007.06.011","doi-asserted-by":"crossref"}],"container-title":["Scandinavian Journal of Gastroenterology"],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/00365521.2013.869351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T03:36:49Z","timestamp":1498102609000},"score":1.0,"issued":{"date-parts":[[2013,12,4]]},"references-count":8,"journal-issue":{"published-online":{"date-parts":[[2013,12,16]]},"published-print":{"date-parts":[[2014,3]]},"issue":"3"},"alternative-id":["10.3109\/00365521.2013.869351"],"URL":"http:\/\/dx.doi.org\/10.3109\/00365521.2013.869351","relation":{"cites":[]},"ISSN":["0036-5521","1502-7708"],"issn-type":[{"value":"0036-5521","type":"print"},{"value":"1502-7708","type":"electronic"}],"subject":["Gastroenterology"],"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=igas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=igas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]},{"indexed":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T20:27:03Z","timestamp":1575404823817},"reference-count":2,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Gastroenterology & Hepatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/meg.0b013e328365aba9","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T19:15:55Z","timestamp":1385493355000},"page":"123","source":"Crossref","is-referenced-by-count":1,"title":["Eradication of Helicobacter pylori infection might have a positive impact on subpopulations with endoscopic gastro-oesophageal reflux disease"],"prefix":"10.1097","volume":"26","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]}],"member":"276","container-title":["European Journal of Gastroenterology & Hepatology"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T03:11:11Z","timestamp":1498101071000},"score":1.0,"subtitle":[""],"issued":{"date-parts":[[2014,1]]},"references-count":2,"journal-issue":{"issue":"1"},"URL":"http:\/\/dx.doi.org\/10.1097\/meg.0b013e328365aba9","ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":["Hepatology","Gastroenterology"]},{"indexed":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T23:46:24Z","timestamp":1575416784691},"reference-count":1,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Gastroenterology & Hepatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/meg.0b013e3283657dfb","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T19:15:17Z","timestamp":1387826117000},"page":"243-244","source":"Crossref","is-referenced-by-count":3,"title":["Active Helicobacter pylori infection on colorectal mucosa \u2013 adenomatous polyp \u2013 adenocarcinoma sequence"],"prefix":"10.1097","volume":"26","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Nikolaos","family":"Kapetanakis","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Iordanis","family":"Romiopoulos","sequence":"additional","affiliation":[]}],"member":"276","container-title":["European Journal of Gastroenterology & Hepatology"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T04:50:09Z","timestamp":1498107009000},"score":1.0,"subtitle":[""],"issued":{"date-parts":[[2014,2]]},"references-count":1,"journal-issue":{"issue":"2"},"URL":"http:\/\/dx.doi.org\/10.1097\/meg.0b013e3283657dfb","ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":["Hepatology","Gastroenterology"]},{"indexed":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T02:25:59Z","timestamp":1575426359711},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.mehy.2013.12.025","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T03:46:17Z","timestamp":1389671177000},"page":"368-373","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders"],"prefix":"10.1016","volume":"82","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Emmanouel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Kazakos","sequence":"additional","affiliation":[]},{"given":"Evangelia","family":"Giartza-Taxidou","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Vardaka","sequence":"additional","affiliation":[]},{"given":"Constantinos","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Boziki","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Giouleme","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T13:02:23Z","timestamp":1565096543000},"score":1.0,"issued":{"date-parts":[[2014,3]]},"references-count":69,"journal-issue":{"published-print":{"date-parts":[[2014,3]]},"issue":"3"},"alternative-id":["S0306987714000139"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2013.12.025","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":["General Medicine"],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T07:45:19Z","timestamp":1575445519491},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00198-014-2673-x","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T16:19:08Z","timestamp":1394036348000},"page":"1633-1642","source":"Crossref","is-referenced-by-count":40,"title":["Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3\u00a0months"],"prefix":"10.1007","volume":"25","author":[{"given":"A. D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"S. A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"P.","family":"Makras","sequence":"additional","affiliation":[]},{"given":"A.","family":"Gkiomisi","sequence":"additional","affiliation":[]},{"given":"I.","family":"Bisbinas","sequence":"additional","affiliation":[]},{"given":"A.","family":"Katsarou","sequence":"additional","affiliation":[]},{"given":"A.","family":"Filippaios","sequence":"additional","affiliation":[]},{"given":"C. S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"2673_CR1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010\u20132018","journal-title":"Lancet"},{"key":"2673_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S24239","volume":"8","author":"AD Anastasilakis","year":"2012","unstructured":"Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P (2012) Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther Clin Risk Manag 8:295\u2013306","journal-title":"Ther Clin Risk Manag"},{"key":"2673_CR3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"A Hodsman","year":"2005","unstructured":"Hodsman A, Bauer D, Dempster D et al (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703","journal-title":"Endocr Rev"},{"key":"2673_CR4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457\u2013465","journal-title":"Nat Rev Endocrinol"},{"key":"2673_CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP et al (2012) A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463\u2013468","journal-title":"Nature"},{"key":"2673_CR6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.metabol.2012.09.002","volume":"61","author":"JY Huh","year":"2012","unstructured":"Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61:1725\u20131738","journal-title":"Metabolism"},{"key":"2673_CR7","doi-asserted-by":"crossref","first-page":"e61903","DOI":"10.1371\/journal.pone.0061903","volume":"8","author":"H Staiger","year":"2013","unstructured":"Staiger H, B\u00f6hm A, Scheler M et al (2013) Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived \u2018browning\u2019 factor irisin, determines insulin sensitivity. PLoS One 8:e61903","journal-title":"PLoS One"},{"key":"2673_CR8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.metabol.2013.04.008","volume":"62","author":"SA Polyzos","year":"2013","unstructured":"Polyzos SA, Kountouras J, Shields K, Mantzoros CS (2013) Irisin: a renaissance in metabolism? Metabolism 62:1037\u20131044","journal-title":"Metabolism"},{"issue":"8","key":"2673_CR9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1210\/en.2012-2162","volume":"154","author":"S Rahman","year":"2013","unstructured":"Rahman S, Lu Y, Czernik PJ, Rosen CJ, Enerback S, Lecka-Czernik B (2013) Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton. Endocrinology 154(8):2687\u20132701","journal-title":"Endocrinology"},{"key":"2673_CR10","unstructured":"Zhang J, Wu Y, Yu L, Meng S, Zhang L, Huang M, Tu Q, Chen JJ (2012) Exercise strengthens bone through myokine irisin. J Bone Miner Res 27 (Suppl 1). Available at http:\/\/www.asbmr.org\/Itinerary\/PresentationDetail.aspx?id=a8a0e3b4-1ca5-4b3e-b35a-307b043e1458 . Accessed 14\u201315 October 2012"},{"key":"2673_CR11","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.metabol.2013.09.016","volume":"62","author":"AD DiVasta","year":"2013","unstructured":"DiVasta AD, Gordon CM (2013) Exercise and bone: where do we stand? Metabolism 62:1714\u20131717","journal-title":"Metabolism"},{"key":"2673_CR12","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1210\/jc.2012-2749","volume":"98","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fern\u00e1ndez-Real JM (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98:E769\u2013E778","journal-title":"J Clin Endocrinol Metab"},{"key":"2673_CR13","doi-asserted-by":"crossref","first-page":"e64025","DOI":"10.1371\/journal.pone.0064025","volume":"8","author":"MS Wen","year":"2013","unstructured":"Wen MS, Wang CY, Lin SL, Hung KC (2013) Decrease in irisin in patients with chronic kidney disease. PLoS One 8:e64025","journal-title":"PLoS One"},{"key":"2673_CR14","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1210\/jc.2010-2317","volume":"95","author":"KE Ensrud","year":"2010","unstructured":"Ensrud KE, Ewing SK, Fredman L, Hochberg MC, Cauley JA, Hillier TA, Cummings SR, Yaffe K, Cawthon PM, Group SoOFR (2010) Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab 95:5266\u20135273","journal-title":"J Clin Endocrinol Metab"},{"key":"2673_CR15","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1210\/jc.2011-1193","volume":"96","author":"MH Murad","year":"2011","unstructured":"Murad MH, Elamin KB, Abu Elnour NO et al (2011) Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997\u20133006","journal-title":"J Clin Endocrinol Metab"},{"key":"2673_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.12188","volume":"79","author":"P Makras","year":"2013","unstructured":"Makras P, Polyzos SA, Papatheodorou A, Kokkoris P, Chatzifotiadis D, Anastasilakis AD (2013) Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis. Clin Endocrinol (Oxf) 79:499\u2013503","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2673_CR17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1507\/endocrj.K07E-123","volume":"55","author":"AD Anastasilakis","year":"2008","unstructured":"Anastasilakis AD, Polyzos SA, Goulis DG, Slavakis A, Efstathiadou Z, Kita M, Koukoulis G, Avramidis A (2008) Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis. Endocr J 55:613\u2013616","journal-title":"Endocr J"},{"key":"2673_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.metabol.2013.11.009","volume":"63","author":"PA Bostr\u00f6m","year":"2014","unstructured":"Bostr\u00f6m PA, Fern\u00e1ndez-Rea JM, Mantzoros CS (2014) Irisin in humans: recent advances and questions for future research. Metabolism 63:178\u2013180","journal-title":"Metabolism"}],"container-title":["Osteoporosis International"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2673-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2673-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:10Z","timestamp":1558624510000},"score":1.0,"issued":{"date-parts":[[2014,3,6]]},"references-count":18,"journal-issue":{"published-print":{"date-parts":[[2014,5]]},"issue":"5"},"alternative-id":["2673"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00198-014-2673-x","relation":{"cites":[]},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":["Endocrinology, Diabetes and Metabolism"]}],"items-per-page":30,"query":{"start-index":0,"search-terms":null}}}